Melatonin secretion and excretion in patients with obstructive sleep apnea syndrome.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Sleep

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/SLEEP/20.11.1002PMID 9456465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of sleep apnea on plasma and urinary catecholamines.

  1995cited by this paper
• Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications.

  1995cited by this paper
• Impaired melatonin secretion in patients with Wernicke‐Korsakoff syndrome

  1995cited by this paper
• Improvement of sleep quality in elderly people by controlled-release melatonin.

  1995cited by this paper
• Beta 2-adrenergic receptor characteristics in sleep apnea patients.

  1995cited by this paper
• Melatonin replacement therapy of elderly insomniacs.

  1995cited by this paper
• Sleep disorders and melatonin rhythms in elderly people

  1994cited by this paper
• Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944.

  1994cited by this paper
• The occurrence of sleep-disordered breathing among middle-aged adults.

  1993cited by this paper
• Augmented resting sympathetic activity in awake patients with obstructive sleep apnea.

  1993cited by this paper
• Inhibition of melatonin secretion by ethanol in man.

  1993cited by this paper
• Age, alcoholism and depression are associated with low levels of urinary melatonin.

  1992cited by this paper
• Nocturnal melatonin secretion in thyroid disease and in obesity

  1991cited by this paper
• Pineal melatonin: cell biology of its synthesis and of its physiological interactions.

  1991cited by this paper
• Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome.

  1991cited by this paper
• Plasma norepinephrine levels in patients with sleep apnea syndrome.

  1990cited by this paper
• A limited diagnostic investigation for obstructive sleep apnea syndrome. Oximetry and static charge sensitive bed.

  1990cited by this paper
• SHORT‐TERM FASTING INHIBITS THE NOCTURNAL MELATONIN SECRETION IN HEALTHY MAN

  1989cited by this paper
• Predictors of objective level of daytime sleepiness in patients with sleep-related breathing disorders.

  1989cited by this paper
• The effect of total sleep deprivation on plasma melatonin and cortisol in healthy human volunteers.

  1988cited by this paper
• Alterations in nocturnal serum melatonin levels in humans with growth and aging.

  1988cited by this paper
• The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome.

  1986cited by this paper
• Abnormal circadian melatonin secretion in night-shift workers.

  1986cited by this paper
• Pineal Function in Burns: Melatonin Is Not a Marker for General Sympathetic Activity

  1984cited by this paper
• The circadian covariation of fatigue and urinary melatonin.

  1982cited by this paper
• Sleep Induction by Intranasal Application of Melatonin

  1981cited by this paper
• Radioimmunological determination of urinary melatonin in humans: correlation with plasma levels and typical 24-hour rhythmicity.

  1981cited by this paper
• Light suppresses melatonin secretion in humans.

  1980cited by this paper
• A simplified radioimmunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man.

  1978cited by this paper
• Melatonin in humans physiological and clinical studies.

  1978cited by this paper
• On the effect of melatonin upon human brain. Its possible therapeutic implications.

  1971cited by this paper
• The fate of melatonin in animals.

  1961cited by this paper

• Circadian biology in obstructive sleep apnea associated cardiovascular disease.

  2025cites this paper
• Rest-activity rhythm disruption and metabolic health in schizophrenia: a cross-sectional actigraphy study of community-dwelling people living with schizophrenia and nonpsychiatric comparison participants

  2024cites this paper
• Consequences and factors associated with OSA: a brief review

  2022cites this paper
• Circadian Biology in Obstructive Sleep Apnea

  2021cites this paper
• Morning Serum Melatonin Levels in Patients with Sleep Apnea Syndrome

  2021cites this paper
• Morning Serum Melatonin Levels in Patients with Sleep Apnea Syndrome

  2021cites this paper
• Update on Persistent Excessive Daytime Sleepiness in Obstructive Sleep Apnea.

  2020cites this paper
• Circadian Melatonin Secretion In Obese Adolescents With Or Without Obstructive Sleep Apnea

  2020cites this paper
• Diurnal and nocturnal serum melatonin concentrations after treatment with continuous positive airway pressure in patients with obstructive sleep apnea.

  2017cites this paper
• Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes

  2017cites this paper
• Beneficial Effects of Serotonin and Melatonin on Cancer, Neurodegenerative Diseases, and Related Disorders in Humans

  2016cites this paper
• Effects of a Postpartum Sleep Schedule on Childless Women's Sleep, Circadian Amplitude, Daytime Sleepiness, Performance, and Mood

  2014cites this paper
• Relationship between melatonin secretion and nighttime blood pressure in elderly individuals with and without antihypertensive treatment: a cross-sectional study of the HEIJO-KYO cohort

  2014cites this paper
• Sleep Disorders and Melatonin

  2014cites this paper
• Melatonin and clock genes expression in the cardiovascular system.

  2013cites this paper
• Melatonin and omentin: influence factors in the obstructive sleep apnoea syndrome?

  2013cites this paper
• Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea.

  2012cites this paper
• Role and Circadian Rhythms of Proinflammatory Cytokines, Cortisol, and Melatonin in Children with Obstructive Sleep Apnea Syndrome

  2007cites this paper
• Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP

  2007cites this paper
• Long‐term effectiveness outcome of melatonin therapy in children with treatment‐resistant circadian rhythm sleep disorders

  2007cites this paper
• Melatonin for treatment of sleep disorders.

  2004cites this paper
• Single-dose bright light and/or caffeine effect on nocturnal performance.

  2002cites this paper
• Arousal threshold to respiratory stimuli in OSA patients: evidence for a sleep-dependent temporal rhythm.

  1999cites this paper
• Melatonin and clinical application.

  1999cites this paper